Search

Tan, Kemin, and Jack Lawler. 2011. “The Structure of the Ca²+-Binding, Glycosylated F-Spondin Domain of F-Spondin - A C2-Domain Variant in an Extracellular Matrix Protein.”. BMC Structural Biology 11: 22.

Cursiefen, Claus, Kazuichi Maruyama, Felix Bock, Daniel Saban, Zahra Sadrai, Jack Lawler, Reza Dana, and Sharmila Masli. 2011. “Thrombospondin 1 Inhibits Inflammatory Lymphangiogenesis by CD36 Ligation on Monocytes.”. The Journal of Experimental Medicine 208 (5): 1083-92.

Kazerounian, Shideh, Mark Duquette, Millys A Reyes, James T Lawler, Keli Song, Carole Perruzzi, Luca Primo, et al. 2011. “Priming of the Vascular Endothelial Growth Factor Signaling Pathway by Thrombospondin-1, CD36, and Spleen Tyrosine Kinase.”. Blood 117 (17): 4658-66.

Ezzie, Michael E, Melissa G Piper, Christine Montague, Christie A Newland, Judy M Opalek, Chris Baran, Naeem Ali, David Brigstock, Jack Lawler, and Clay B Marsh. 2011. “Thrombospondin-1-Deficient Mice Are Not Protected from Bleomycin-Induced Pulmonary Fibrosis.”. American Journal of Respiratory Cell and Molecular Biology 44 (4): 556-61.

Tan, Kemin, Mark Duquette, Andrzej Joachimiak, and Jack Lawler. 2009. “The Crystal Structure of the Signature Domain of Cartilage Oligomeric Matrix Protein: Implications for Collagen, Glycosaminoglycan and Integrin Binding.”. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 23 (8): 2490-501.

Sun, Jingfang, Benjamin D Hopkins, Kaoru Tsujikawa, Carole Perruzzi, Irit Adini, Robert Swerlick, Paul Bornstein, Jack Lawler, and Laura E Benjamin. 2009. “Thrombospondin-1 Modulates VEGF-A-Mediated Akt Signaling and Capillary Survival in the Developing Retina.”. American Journal of Physiology. Heart and Circulatory Physiology 296 (5): 1344-51.

Posey, Karen L, Kurt Hankenson, Alka C Veerisetty, Paul Bornstein, Jack Lawler, and Jacqueline T Hecht. 2008. “Skeletal Abnormalities in Mice Lacking Extracellular Matrix Proteins, Thrombospondin-1, Thrombospondin-3, Thrombospondin-5, and Type IX Collagen.”. The American Journal of Pathology 172 (6): 1664-74.

Kazerounian, S, K O Yee, and J Lawler. 2008. “Thrombospondins in Cancer.”. Cellular and Molecular Life Sciences : CMLS 65 (5): 700-12.

Daniel, Christoph, Kathrin Schaub, Kerstin Amann, Jack Lawler, and Christian Hugo. 2007. “Thrombospondin-1 Is an Endogenous Activator of TGF-Beta in Experimental Diabetic Nephropathy in Vivo.”. Diabetes 56 (12): 2982-9.

Zhang, Xuefeng, Caitlin Connolly, Mark Duquette, Jack Lawler, and Sareh Parangi. 2007. “Continuous Administration of the Three Thrombospondin-1 Type 1 Repeats Recombinant Protein Improves the Potency of Therapy in an Orthotopic Human Pancreatic Cancer Model.”. Cancer Letters 247 (1): 143-9.